While it is unclear whether and how the Trump proposals will be implemented, the Trump policies are likely to have a negative impact on the pharmaceutical industry and may have a negative impact on our ability to receive adequate revenues for WAKIX.
All entries for: Harmony Biosciences Holdings, Inc.
February 24, 2026
Harmony Biosciences Holdings, Inc.
Neutral Outlook
Plymouth Meeting, PA
201-500 employees
The Inflation Reduction Act (the “IRA”) was enacted in 2022. This statute marks the most significant action by Congress with respect to the pharmaceutical industry since adoption of the ACA in 2010. Among other things, the IRA requires manufacturers of certain drugs to engage in price negotiations with Medicare, with prices that can be negotiated subject to a cap
Disease Area: Neurological Diseases, Rare Diseases
Drug Type: Biologic, Small Molecule